These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26446420)

  • 41. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
    Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice.
    Wu XX; Deng XL; Yu DS; Yao W; Ou HL; Weng TH; Hu CY; Hu FY; Wu NP; Yao H; Zhang FC; Li LJ
    Cell Physiol Biochem; 2018; 46(2):633-643. PubMed ID: 29617693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early Antibody Response Contributes to the Virus Eradication and Clinical Recovery of H7N9 Influenza Infection.
    Liu X; Yang Z; Yuan J; Liao J; Duan L; Wang W; Zhang F; Chen X; Zhou B
    Ann Clin Lab Sci; 2017 Sep; 47(5):592-599. PubMed ID: 29066487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serologic assay for avian-origin influenza A (H7N9) virus in adults of Shanghai, Guangzhou and Yunnan, China.
    Wang W; Peng H; Tao Q; Zhao X; Tang H; Tang Z; Wang Y; Wang Y; Zhao P; Qi Z
    J Clin Virol; 2014 Jul; 60(3):305-8. PubMed ID: 24793969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
    Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
    Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
    Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC
    Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    Liu L; Nachbagauer R; Zhu L; Huang Y; Xie X; Jin S; Zhang A; Wan Y; Hirsh A; Tian D; Shi X; Dong Z; Yuan S; Hu Y; Krammer F; Zhang X; Xu J
    J Infect Dis; 2017 Feb; 215(4):518-528. PubMed ID: 28380622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nosocomial Co-Transmission of Avian Influenza A(H7N9) and A(H1N1)pdm09 Viruses between 2 Patients with Hematologic Disorders.
    Chen H; Liu S; Liu J; Chai C; Mao H; Yu Z; Tang Y; Zhu G; Chen HX; Zhu C; Shao H; Tan S; Wang Q; Bi Y; Zou Z; Liu G; Jin T; Jiang C; Gao GF; Peiris M; Yu H; Chen E
    Emerg Infect Dis; 2016 Apr; 22(4):598-607. PubMed ID: 26982379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
    Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
    J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
    van de Sandt CE; Kreijtz JH; de Mutsert G; Geelhoed-Mieras MM; Hillaire ML; Vogelzang-van Trierum SE; Osterhaus AD; Fouchier RA; Rimmelzwaan GF
    J Virol; 2014 Feb; 88(3):1684-93. PubMed ID: 24257602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection Against H7 Subtype Influenza Virus Infection in Mice by Passive Transfer of Neutralizing Monoclonal Antibody.
    Zhang Z; Liu M; Zheng S
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):360-5. PubMed ID: 26492625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
    Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
    Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The first lack of evidence of H7N9 avian influenza virus infections among pigs in Eastern China.
    Zhao FR; Zhou DH; Lin T; Shao JJ; Wei P; Zhang YG; Chang HY
    Microb Pathog; 2015 Mar; 80():63-6. PubMed ID: 25680835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
    Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9.
    Huang R; Zhang L; Gu Q; Zhou YH; Hao Y; Zhang K; Liu Y; Dong D; Wang S; Huang Z; Lu S; Wu C
    PLoS One; 2014; 9(7):e101788. PubMed ID: 25003343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus.
    Rudenko L; Isakova-Sivak I; Donina S
    Vaccine; 2013 Oct; 31(42):4702-5. PubMed ID: 23988294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic.
    Kumagai T; Nakayama T; Okuno Y; Kase T; Nishimura N; Ozaki T; Miyata A; Suzuki E; Okafuji T; Okafuji T; Ochiai H; Nagata N; Tsutsumi H; Okamatsu M; Sakoda Y; Kida H; Ihara T
    Viral Immunol; 2014 Oct; 27(8):368-74. PubMed ID: 25211638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influenza A(H7N9) Virus Antibody Responses in Survivors 1 Year after Infection, China, 2017.
    Ma MJ; Liu C; Wu MN; Zhao T; Wang GL; Yang Y; Gu HJ; Cui PW; Pang YY; Tan YY; Hang H; Lin B; Qin JC; Fang LQ; Cao WC; Cheng LL
    Emerg Infect Dis; 2018 Apr; 24(4):663-672. PubMed ID: 29432091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.